If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

Introduction Efficient preventive management of acute exacerbation of chronic obstructive pulmonary disease (COPD) is ...

MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the commercial launch in Europe of both the ...

The upcoming hardware targets the living room again with a compact cube design, lottery reservations, and Steam Frame VR ...